Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518245
Status:
TERMINATED
Last Update Posted:
2016-01-27
First Post:
2007-08-16
Brief Title:
Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk IDEAL
Sponsor:
Canadian Heart Research Centre
Organization:
Canadian Heart Research Centre
Study Overview
Official Title:
A Prospective Open Label Randomized Parallel-group Investigation to Evaluate the Efficacy and Safety of Enoxaparin Versus no Enoxaparin in Subjects With Chest Pain Syndrome and no ECG or Biomarker Abnormalities
Status:
TERMINATED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Low rate of patient recruitment Cannot achieve sample size
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IDEAL
Brief Summary:
The purpose of this study is to determine whether enoxaparin an anticoagulant is effective in the treatment of patients presenting to the emergency room with chest pain and no electrocardiogram or bloodwork evidence of a heart attack but with other high risk clinical features
Detailed Description:
Patients with chest pain and abnormal electrocardiogram or bloodwork biomarker indicative of a heart attack benefit from anticoagulant therapy such as enoxaparin However even patients without abnormalities on the electrocardiogram or bloodwork are at increased risk for heart attack or death if they have certain clinical risk factors It is currently not known whether enoxaparin is also beneficial for these patients
Comparison enoxaparin in addition to optimal standard care at the discretion of the treating physician versus optimal standard care without enoxaparin
Comparison enoxaparin in addition to optimal standard care at the discretion of the treating physician versus optimal standard care without enoxaparin
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None